BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Allergy to pollen
,
Leukocyte
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
WAS 406
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute myeloid lymphoma cell lines treated with SYK inhibitor R406
DLBCL cell lines, DHL4, DHL6, LY7, HBL1 and U2932, treated with the SYK inhibitor, R406
Diffuse large B cell lymphoma DHL4 or DHL6 cells in a treatment time course with R406
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine resul…
The NASOROSSO (Rednose) project: an Italian study on alcohol consumption in recreational places.
Collagen crosslinking for ectasia following PRK performed in excimer laser-assisted keratoplasty for…
Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a …
Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SARC021C: A Continuation Study of TH-CR-406/SARC021
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors an…
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors
Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leu…
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ